首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Immunomodulatory Effects of Kuseonwangdogo-Based Mixed Herbal Formula Extracts on a Cyclophosphamide-Induced Immunosuppression Mouse Model
【24h】

Immunomodulatory Effects of Kuseonwangdogo-Based Mixed Herbal Formula Extracts on a Cyclophosphamide-Induced Immunosuppression Mouse Model

机译:基于Kuseonwangdogo的混合草药配方提取物对环磷酰胺诱导的免疫抑制小鼠模型的免疫调节作用。

获取原文
           

摘要

Aim. Kuseonwangdogo is a traditional Korean immunomodulatory polyherbal prescription. However, there are no systemic findings on its complex immunomodulatory effects on in vivo models. In this study, we observed the immunomodulatory effects of Kuseonwangdogo-based mixed herbal formula aqueous extracts (MHFe) on cyclophosphamide- (CPA-) induced immunosuppression mouse model. Methods. In total, 60 male 6-week-old ICR mice (10 mice/group) were selected based on body weight 24 h after the second CPA treatment and used in this experiment. Twelve hours after the end of the last (fourth) oral administration of MHFe, the animals were sacrificed. Results. Following CPA treatment, a noticeable decrease in the body, thymus, spleen, and submandibular lymph node (LN) weights; white blood cell, red blood cell, platelet number, hemoglobin, and hematocrit concentrations; serum interferon-γ levels; splenic tumor necrosis factor-α, interleukin- (IL-) 1β, and IL-10 content; and peritoneal and splenic natural killer cell activities was observed. Depletion of lymphoid cells in the thymic cortex, splenic white pulp, and submandibular LN-related atrophic changes were also observed. However, these CPA-induced myelosuppressive signs were markedly and dose-dependently inhibited by the oral administration of 125, 250, and 500 mg/kg MHFe. Conclusion. MHFe can be a promising, potent immunomodulatory therapeutic agent for various immune disorders.
机译:目标。 Kuseonwangdogo是韩国传统的免疫调节多草药处方。但是,没有关于其对体内模型的复杂免疫调节作用的系统性发现。在这项研究中,我们观察到基于Kuseonwangdogo的混合草药配方水提取物(MHFe)对环磷酰胺(CPA-)诱导的免疫抑制小鼠模型的免疫调节作用。方法。根据第二次CPA治疗后24小时的体重,总共选择了60只6周龄的ICR雄性小鼠(每组10只小鼠),并用于本实验。在最后一次(第四次)口服MHFe结束后十二小时,处死动物。结果。 CPA治疗后,身体,胸腺,脾脏和下颌下淋巴结(LN)的重量明显减少;白细胞,红细胞,血小板数量,血红蛋白和血细胞比容浓度;血清γ-干扰素水平;脾肿瘤坏死因子-α,白介素-(IL-)1β和IL-10含量;并观察到腹膜和脾自然杀伤细胞活性。还观察到胸腺皮质,脾脏白髓和下颌下LN相关萎缩性变化中的淋巴样细胞减少。但是,口服125、250和500μmg/ kg MHFe可以显着和剂量依赖性地抑制这些CPA诱导的骨髓抑制体征。结论。 MHFe对各种免疫疾病可能是一种有前途的有效免疫调节治疗剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号